Potential contamination of the active substance Valsartanum with NDMA and NDEA was detected, which required suspension from the market until confirmation that levels were below acceptable limits. Potential effects: possible carcinogenic effect, complications with long‑term use.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Patients using Valzek 80 mg may continue therapy as prescribed; if in doubt, they should consult their doctor or pharmacist and check GIF communications regarding specific batches.
Initially, all batches of Valzek 80 mg containing Valsartanum from the specified supplier were suspended from the market due to suspected NDMA and NDEA contamination, and subsequently, after test resu...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related